Saturday 17 October 2026
Export NTRA’s income statement to Excel — free account
Natera, Inc.
NTRA Healthcare Diagnostics & Research
Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024. In the quarter to June 2026, revenue grew 37.7%, EPS grew 36.5%, free cash flow fell 174.0% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
391.98
12.81
−3.16%
Follow NTRA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 6 | 6 |
| (29.02%) | (14.32%) | (15.02%) | (12.54%) | ||
| (18.12%) | (10.26%) | (10.41%) | (8.71%) | ||
ROIC |
(75.81%) | (27.03%) | (26.44%) | (22.34%) | |
Return on Tangible Assets |
(25.51%) | (16.05%) | (16.60%) | (13.51%) | |
Average Days of Receivables |
49.38 | 46.93 | 60.95 | 56.89 | |
Free Cash Flow per Share |
0.77 | 0.80 | 0.74 | 0.59 | |
Free Cash Flow |
106.07 | 109.11 | 104.51 | 84.20 | |
Capital Expenditures |
(88.23) | (106.19) | (106.51) | (144.04) | |
| Other line items | |||||
Cash ROIC |
4.47% | 3.80% | 3.55% | 2.81% | |
Accounts Receivable Turnover |
7.14 | 7.55 | 6.80 | 7.40 | |
Accounts Payable Turnover |
20.70 | 23.88 | 17.19 | 16.80 | |
Inventory Turnover |
13.57 | 14.36 | 14.43 | 13.98 | |
Average Days of Payables |
22.06 | 14.89 | 26.07 | 29.14 | |
Days of Inventory on Hand |
30.67 | 30.73 | 29.55 | 31.16 | |
Tax Rate |
0.00 | (0.22) | (0.21) | (0.24) | |
Research and Development Expense of Revenue |
27.32% | 27.06% | 28.22% | 29.09% | |
Selling, General and Administrative Expense of Revenue |
52.95% | 51.05% | 49.52% | 46.36% | |
Share Based Compensation of Revenue |
15.77% | 15.37% | 14.86% | 14.09% | |
Interest Coverage |
(80.50) | (76.16) | (81.96) | (75.89) | |
Operating CF/Net income |
(0.63) | (1.03) | (0.93) | (1.19) | |
Depreciation/Fixed assets |
0.18 | 0.18 | 0.20 | 0.21 | |
Capex/Depreciation |
(2.37) | (2.44) | (1.95) | (2.19) | |
Revenue per Share |
15.43 | 16.87 | 17.67 | 18.89 | |
Operating CF per Share |
1.42 | 1.57 | 1.49 | 1.59 | |
Capex per Share |
(0.64) | (0.78) | (0.75) | (1.01) | |
Capex to Sales |
0.04 | 0.05 | 0.04 | 0.05 |
Columns are period end dates